• Arcutis schedules Q2 2026 financial results release for Aug. 5, 2026, following the U.S. market close.
• Conference call, webcast set for Aug. 5, 2026 at 4:30 p.m. ET via the company website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607151600PRIMZONEFULLFEED9760585) on July 15, 2026, and is solely responsible for the information contained therein.